- Home
- ALLY vs SNN Comparison
ALLY vs SNN Comparison
Compare ALLY & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLY
- SNN
- Stock Information
- Founded
- ALLY 1919
- SNN 1856
- Country
- ALLY United States
- SNN United Kingdom
- Employees
- ALLY N/A
- SNN N/A
- Industry
- ALLY Major Banks
- SNN Industrial Specialties
- Sector
- ALLY Finance
- SNN Health Care
- Exchange
- ALLY Nasdaq
- SNN Nasdaq
- Market Cap
- ALLY 11.3B
- SNN 13.2B
- IPO Year
- ALLY 2014
- SNN 1999
- Fundamental
- Price
- ALLY $40.53
- SNN $30.28
- Analyst Decision
- ALLY Buy
- SNN Hold
- Analyst Count
- ALLY 18
- SNN 3
- Target Price
- ALLY $43.33
- SNN $27.50
- AVG Volume (30 Days)
- ALLY 3.1M
- SNN 1.2M
- Earning Date
- ALLY 07-18-2025
- SNN 07-31-2025
- Dividend Yield
- ALLY 2.97%
- SNN 2.37%
- EPS Growth
- ALLY N/A
- SNN 56.15
- EPS
- ALLY 0.61
- SNN 0.47
- Revenue
- ALLY $6,658,000,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- ALLY $20.25
- SNN $6.87
- Revenue Next Year
- ALLY $14.86
- SNN $5.19
- P/E Ratio
- ALLY $66.12
- SNN $33.29
- Revenue Growth
- ALLY N/A
- SNN 4.70
- 52 Week Low
- ALLY $29.52
- SNN $23.69
- 52 Week High
- ALLY $45.46
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- ALLY 68.94
- SNN 54.96
- Support Level
- ALLY $40.22
- SNN $29.50
- Resistance Level
- ALLY $41.28
- SNN $31.43
- Average True Range (ATR)
- ALLY 0.80
- SNN 0.42
- MACD
- ALLY 0.07
- SNN 0.02
- Stochastic Oscillator
- ALLY 83.40
- SNN 56.27
About ALLY Ally Financial Inc.
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.